Pfizer Inc. Accounts Payable for the year ending December 31, 2024: USD 5.63 B

Pfizer Inc. Accounts Payable is USD 5.63 B for the year ending December 31, 2024, a -16.05% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Pfizer Inc. Accounts Payable for the year ending December 31, 2023 was USD 6.71 B, a -1.45% change year over year.
  • Pfizer Inc. Accounts Payable for the year ending December 31, 2022 was USD 6.81 B, a 22.07% change year over year.
  • Pfizer Inc. Accounts Payable for the year ending December 31, 2021 was USD 5.58 B, a 30.24% change year over year.
  • Pfizer Inc. Accounts Payable for the year ending December 31, 2020 was USD 4.28 B, a 10.19% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities